<DOC>
	<DOCNO>NCT02922712</DOCNO>
	<brief_summary>Study conduct evaluate safety efficacy patient osteoarthritis</brief_summary>
	<brief_title>Evaluation Efficacy Safety Nise 100 mg Management Osteoarthrosis ( Gonarthrosis )</brief_title>
	<detailed_description>Osteoarthritis common disorder joint , give page 10 % world population age 45 year ( Woolf A. D. , Pfleger B. , Bergman S. , 2009 ) . The main clinical manifestation disease pain joint violation function . Therefore , one first task therapeutic program , patient decrease possible pain relief . Nesteroi dnye anti-inflammatory drug ( NSAIDs ) main group medicine drug use medical practice lech th Research Institute pain patient lesion musculoskeletal system . The basis therapeutic effect second drug suppression activity Fe p IU NTA cyclooxygenase ( COX ) . Prichё , suppression activity COX-2 isoenzyme involve synthesis prostaglandin , induce development pain PLAYBACK tion provide anti-inflammatory effect NSAIDs . B Blocking enzyme COX-1 , control synthesis prostaglandin , cite protective property , lead side effect NSAIDs These call nye form basis creation new NSAIDs selectively inhibit COX-2 mally affect COX . - 1 . Nimesulide selective inhibitor cyclooxygenase -2 vnym Sat anced analgesic anti-inflammatory effect , also antibradikinin , antihistamine antioxidant activity Stu ( Nasonov EL , 1999 , 2001 ) .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Nimesulide</mesh_term>
	<criteria>patient 40 year old old verify diagnosis OA knee joint accord criterion American College Rheumatology ( АСR ) ; radiologic abnormality comply IIII grade Kellgren ; pain syndrome less 40 point accord 100point visual analogue scale ( VAS ) . A history patient within last 5 year malignancy organ system regardless whether treatment carry occasion elk . The presence acute ulcer disease gastrointestinal tract , several recent year . Any data bleeding upper gastrointestinal tract . Severe disease : uncontrolled hypertension , expression n naya cardiovascular failure , pathology hematopoietic system , mellitus type I , others . The presence rheumatic disease exception teoartroza . Liver disease ( cirrhosis , chronic hepatitis ) . Abnormal liver function ( ALT , AST , bilirubin 1.5 time upper limit normal ) . Impaired renal function ( blood creatinine 1.5 time higher 's v limit normal ) . Anemia ( g emoglobin 10 g / l less low limit normal ) . Treatment corticosteroid ( systemic reception ) , warfarin coumarin governmental produ d. Hypersensitivity analgesic antipyretic Wed stvam , NSAIDs , sulfonamide . Pregnancy lactation . Alcohol drug abuse history .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>